These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 31058792)
1. Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience. Tokatly Latzer I; Nahum E; Cavari Y; Lazar I; Ben-Ari Y; Ben-Shimol S; Ben-Shalom G; Geffen Y; Goldberg L; Rubinstein M; Keller N; Pessach IM; Paret G Pediatr Crit Care Med; 2019 May; 20(5):e231-e239. PubMed ID: 31058792 [TBL] [Abstract][Full Text] [Related]
2. Management of Stenotrophomonas maltophilia Infections in Critically Ill Children. Tokatly Latzer I; Paret G; Rubinstein M; Keller N; Barkai G; Pessach IM Pediatr Infect Dis J; 2018 Oct; 37(10):981-986. PubMed ID: 29634621 [TBL] [Abstract][Full Text] [Related]
3. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate. Alsuhaibani M; Aljarbou A; Althawadi S; Alsweed A; Al-Hajjar S Antimicrob Resist Infect Control; 2021 Jan; 10(1):19. PubMed ID: 33482916 [TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series. Ebara H; Hagiya H; Haruki Y; Kondo E; Otsuka F Intern Med; 2017; 56(2):137-142. PubMed ID: 28090041 [TBL] [Abstract][Full Text] [Related]
5. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study. Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988 [TBL] [Abstract][Full Text] [Related]
6. Clinical Features, Outcomes, and Risk Factors of Bloodstream Infections due to Chen Y; Suo J; Du M; Chen L; Liu Y; Wang L; Liang Z Biomed Res Int; 2019; 2019():4931501. PubMed ID: 31886220 [No Abstract] [Full Text] [Related]
7. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains. Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for death from Stenotrophomonas maltophilia bacteremia. Osawa K; Shigemura K; Kitagawa K; Tokimatsu I; Fujisawa M J Infect Chemother; 2018 Aug; 24(8):632-636. PubMed ID: 29673561 [TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. Ko JH; Kang CI; Cornejo-Juárez P; Yeh KM; Wang CH; Cho SY; Gözel MG; Kim SH; Hsueh PR; Sekiya N; Matsumura Y; Lee DG; Cho SY; Shiratori S; Kim YJ; Chung DR; Peck KR Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331 [TBL] [Abstract][Full Text] [Related]
10. Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. Hand E; Davis H; Kim T; Duhon B J Antimicrob Chemother; 2016 Apr; 71(4):1071-5. PubMed ID: 26801080 [TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology and characteristics of 16 cases with Stenotrophomonas maltophilia bacteraemia in pediatric Intensive Care Units. Motamedifar M; Heidari H; Yasemi M; Sedigh Ebrahim-Saraie H Ann Ig; 2017; 29(4):264-272. PubMed ID: 28569336 [TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy. Kim SH; Cho SY; Kang CI; Seok H; Huh K; Ha YE; Chung DR; Lee NY; Peck KR; Song JH Ann Hematol; 2018 Feb; 97(2):343-350. PubMed ID: 29138886 [TBL] [Abstract][Full Text] [Related]
13. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis. Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of Stenotrophomonas maltophilia bacteremia in children. Furuichi M; Ito K; Miyairi I Pediatr Int; 2016 Feb; 58(2):113-8. PubMed ID: 26139084 [TBL] [Abstract][Full Text] [Related]
15. Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections. Watson L; Esterly J; Jensen AO; Postelnick M; Aguirre A; McLaughlin M J Glob Antimicrob Resist; 2018 Mar; 12():104-106. PubMed ID: 28964955 [TBL] [Abstract][Full Text] [Related]
16. Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial Hevia EC; Wooten L; Carr AL Ann Pharmacother; 2024 Jul; 58(7):698-704. PubMed ID: 37776160 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467 [TBL] [Abstract][Full Text] [Related]
18. Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience. Arthur C; Tang X; Romero JR; Gossett JG; Harik N; Prodhan P Pediatr Cardiol; 2015 Mar; 36(3):509-15. PubMed ID: 25293429 [TBL] [Abstract][Full Text] [Related]
19. Stenotrophomonas maltophilia bacteraemia in Turkish children. Güriz H; Ciftçi E; Ayberkin E; Aysev D; Ince E; Arsan S; Yavuz G; Doğru U Ann Trop Paediatr; 2008 Jun; 28(2):129-36. PubMed ID: 18510823 [TBL] [Abstract][Full Text] [Related]
20. Stenotrophomonas maltophilia bacteremia in children - A 10-year analysis. Büyükcam A; Bıçakcıgil A; Cengiz AB; Sancak B; Ceyhan M; Kara A Arch Argent Pediatr; 2020 Jun; 118(3):e317-e323. PubMed ID: 32470274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]